Antidiabetes wars: a new hope

    Article metrics

    Access options

    Rent or Buy article

    Get time limited or full article access on ReadCube.

    from$8.99

    All prices are NET prices.

    References

    1. 1

      Choi, J.H. et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5. Nature 466, 451–456 (2010).

    2. 2

      Lehrke, M. & Lazar, M.A. The many faces of PPARγ. Cell 123, 993–999 (2005).

    3. 3

      Gronemeyer, H., Gustafsson, J.A. & Laudet, V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3, 950–964 (2004).

    4. 4

      Olefsky, J.M. and Glass, C.K. Macrophage, inflammation and insulin resistance. Ann. Rev. Physiol. 72, 219–246 (2010).

    5. 5

      Vernochet, C. et al. C/EBPα and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor γ agonists. Mol. Cell Biol. 29, 4714–4728 (2010).

    Download references

    Ethics declarations

    Competing interests

    M.A.L. has served as a consultant to GlaxoSmithKline, Eli Lilly and Dr. Reddy's Laboratories.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Antidiabetes wars: a new hope. Nat Med 16, 972–973 (2010) doi:10.1038/nm0910-972

    Download citation

    Further reading